Amikacin sulfate is an intravenous drug used for the short-term treatment of a variety of bacterial infections. The presence of glass particulate in the drug could result in irritation, swelling and blood clots.
The recalled lots were distributed to wholesalers, retailers and pharmacies across the country. Teva issued an Urgent Drug Recall Letter to customers, urging them to stop use or distribution and quarantine the product immediately.
So far, Israel-based Teva has not received any reports of adverse events or complaints over the recall.
More articles on supply chain:
Express Scripps adds new drugs to its exclusion list
Teva must divest 79 generics to acquire Allergan’s generic pharma for $40.5 billion
America’s Essential Hospitals partners with Premier to improve supply chain management
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
